BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 25391920)

  • 1. Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.
    Shi M; Wang Z; Liu XY; Chen D
    Med Oncol; 2014 Dec; 31(12):309. PubMed ID: 25391920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
    Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer.
    Sun ZG; Wang Z
    Dis Esophagus; 2011 Apr; 24(3):182-8. PubMed ID: 21073618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFAIP8 overexpression: a potential predictor of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor Lewis esophagectomy.
    Sun Z; Liu X; Song JH; Cheng Y; Liu Y; Jia Y; Meltzer SJ; Wang Z
    Tumour Biol; 2016 Aug; 37(8):10923-34. PubMed ID: 26886285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of RUNX3 protein in human esophageal mucosa and squamous cell carcinoma.
    Hiramatsu T; Osaki M; Ito Y; Tanji Y; Tokuyasu N; Ito H
    Pathobiology; 2005; 72(6):316-24. PubMed ID: 16582583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of claudin-4: an indicator of recurrence in esophageal squamous cell carcinoma after Ivor Lewis esophagectomy?
    Shi M; Wang Z; Song L; Wang D; Sun Z
    Med Oncol; 2014 May; 31(5):951. PubMed ID: 24737010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
    Li DJ; Shi M; Wang Z
    Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
    Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
    Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
    Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial‑mesenchymal transition through TGF‑β/Smad signaling.
    Xiao Z; Tian Y; Jia Y; Shen Q; Jiang W; Chen G; Shang B; Shi M; Wang Z; Zhao X
    Oncol Rep; 2020 Apr; 43(4):1289-1299. PubMed ID: 32323849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between secreted protein acidic and rich in cysteine protein expression and the prognosis of postoperative patients exhibiting esophageal squamous cell carcinoma.
    Wu J; Zhang JR; Jiang XQ; Cao XG
    Mol Med Rep; 2017 Sep; 16(3):3401-3406. PubMed ID: 28713937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.
    Sun ZG; Wang Z; Zhang M
    Asia Pac J Clin Oncol; 2012 Dec; 8(4):e68-76. PubMed ID: 22897688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic significance of HMGA2 expression's correlation with prognosis of esophageal squamous cell carcinoma after Ivor Lewis esophagectomy.
    Zhang M; Hu D; Wang S; Qin C
    Minerva Chir; 2016 Aug; 71(4):239-44. PubMed ID: 27119517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of IFITM3 predicts poor prognosis in stage IIA esophageal squamous cell carcinoma after Ivor Lewis esophagectomy.
    Jia Y; Xiao Z; Jiang W; Chen G; Wang Z
    Thorac Cancer; 2017 Nov; 8(6):592-599. PubMed ID: 28857475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.
    Wang S; Wang Z; Liu X; Yang Y; Shi M; Sun Z
    Tumour Biol; 2015 Aug; 36(8):6181-9. PubMed ID: 25758053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Li LY; Li EM; Wu ZY; Cao HH; Shen JH; Xu XE; Chen B; Wu JY; Xu LY
    Int J Clin Exp Pathol; 2014; 7(6):3132-40. PubMed ID: 25031732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
    Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
    Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
    Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
    Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
    Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.